Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial

Authors: Frederick J. Raal, Raúl D. Santos, Dirk Blom, A. David Marais, Min‐Ji Charng, William C. Cromwell, Robin Lachmann, Daniel Gaudet, Ju Le Tan, Scott Chasan-Taber, Diane L. Tribble, JoAnn Flaim, Stanley T. Crooke - The Lancet 2010 cited by 906